Zentalis Pharmaceuticals
ZNTL
ZNTL
106 hedge funds and large institutions have $1.29B invested in Zentalis Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 48 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
2% more capital invested
Capital invested by funds: $1.27B → $1.29B (+$27.5M)
12% less funds holding
Funds holding: 120 → 106 (-14)
70% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 20
Holders
106
Holding in Top 10
5
Calls
$1.58M
Puts
$24K
Top Buyers
| 1 | +$61.4M | |
| 2 | +$18.7M | |
| 3 | +$9.99M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$8.47M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.84M |
Top Sellers
| 1 | -$4.96M | |
| 2 | -$3.68M | |
| 3 | -$3.49M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$3.44M |
| 5 |
Walleye Capital
New York
|
-$1.85M |